HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elimination of cefmenoxime during continuous haemofiltration.

Abstract
The elimination of cefmenoxime after single and repeated i.v. dosing was studied in 12 patients with severe renal failure and sepsis during continuous haemofiltration. More than 30% of the drug was found in the filtrate. The sieving coefficient (S) was 0.54. Vss% was unchanged 0.31 l.kg-1 in comparison with patients with normal renal function, whereas the mean t1/2ss was prolonged to about 16 h, and total clearance was reduced 20.8 ml.min-1.1.73 m-2. Once daily administration of 1 g cefmenoxime is suggested as the appropriate dose under such circumstances.
AuthorsJ Evers, K Borner, P Koeppe
JournalEuropean journal of clinical pharmacology (Eur J Clin Pharmacol) Vol. 44 Suppl 1 Pg. S31-2 ( 1993) ISSN: 0031-6970 [Print] Germany
PMID8486144 (Publication Type: Journal Article)
Chemical References
  • Cefmenoxime
Topics
  • Adult
  • Aged
  • Cefmenoxime (administration & dosage, pharmacokinetics)
  • Chromatography, High Pressure Liquid
  • Female
  • Half-Life
  • Hemofiltration
  • Humans
  • Kidney Failure, Chronic (metabolism, therapy)
  • Male
  • Middle Aged
  • Regression Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: